NICE Recommends Givinostat for Duchenne Muscular Dystrophy
NICE has recommended givinostat for all DMD types, offering around 530 patients a drug that may delay disease progression by up to 5 years. Medscape News UK
Original Source
Read the full article at Medscape →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.